510(k) K112933
K112933 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "ACCESS THYROGLOBULIN ANITBODY". The FDA issued a decision of Substantially Equivalent on December 27, 2011. The device falls under product code JNL (Immunochemical, Thyroglobulin Autoantibody), a Class II device regulated under 21 CFR 866.5870. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 27, 2011
- Date Received
- October 3, 2011
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Immunochemical, Thyroglobulin Autoantibody
- Device Class
- Class II
- Regulation Number
- 866.5870
- Review Panel
- IM
- Submission Type